TB-500
Thymosin Beta-4 Fragment
Healing Peptide
Peptide
D
T3 Basic
Peptide
Unregulated Substance
Not FDA approved. Safety and efficacy not fully established. Consult a healthcare provider before use.
US: unregulatedEU: unregulated
Synthetic fragment of Thymosin Beta-4. Promotes systemic tissue repair and reduces inflammation.
Mechanism of Action
Promotes cell migration, angiogenesis, and tissue repair through actin regulation.
Usage Tips
- Typically dosed weekly (split or single)
- Often stacked with BPC-157
- Systemic effects vs BPC-157 local
- Research chemical - limited human data
Contraindications
- Active cancer
- Pregnancy
- Unknown long-term safety
Performance Profile
Sleep Quality
—
Sleep Onset
—
Deep Sleep
—
Recovery Speed
D+5
Dosage
2mg/week
min
5mg/week
10mg/week
max
Timing
Best time
Anytime
1 wk
onset
2 wk
duration
Half-life
3 dSafety & Legal
5/10
Use caution
Legal Status
Unregulated
US & EU
mild
moderate
severe
Injection site irritation
1-10%mild
Lethargy
0.1-1%mild
Head rush
0.1-1%mild